Survival, mortality and causes of death in inflammatory myopathies

被引:74
作者
Torres, C
Belmonte, R
Carmona, L
Gómez-Reino, FJ
Galindo, M
Ramos, B
Cabello, A
Carreira, PE
机构
[1] Hosp 12 Octubre, Serv Reumatol, E-28041 Madrid, Spain
[2] Sociedad Espanola Reumatol, Unidad Invest, Madrid 28001, Spain
[3] Hosp 12 Octubre, Unidad Reumatol Infantil, E-28041 Madrid, Spain
[4] Hosp 12 Octubre, Dept Anat Patol, Unidad Neuropatol, E-28041 Madrid, Spain
关键词
inflammatory myopathies; survival; mortality; risk factors for mortality;
D O I
10.1080/08916930600622603
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective : To investigate the causes of death, survival and clinical factors associated with mortality, in a group of Spanish patients with inflammatory myopathies (IM) followed in the same University Hospital during a 25 year period. Methods : A cross sectional study was performed, including 107 patients diagnosed with IM according to the Bohan and Peter criteria. Demographical and clinical information were extracted from the charts. Bivariate odds ratio with 95% confidence interval (CI) was used to measure the strength of association between variables. Kaplan-Meyer analysis was used to estimate survival. Univariate and multivariate Cox regression analysis were used to study clinical associations with mortality. Results : Twenty-eight patients (26%) died. Deaths were considered to be disease related in 21 cases. Main causes of death were cancer extension, cardiac involvement and lung involvement. Survival for the whole group was 92, 80 and 71% after 1, 5 and 10 years, respectively. By the log rank test, survival was lower for patients with cancer (p = 0.0001) as well as in those with cardiac involvement (p < 0.0001), compared to patients without these conditions. Cox univariate analysis showed that mortality was associated with higher age at IM onset, left ventricular dysfunction, and the presence of cancer and the smoking habit. In Cox multivariate analysis, only left ventricular dysfunction (HR 4.6; 95%CI 2.0-10.3; p > 0.0001) and the presence of cancer (HR = 3.3; 95%CI 1.4-7.4; p = 0.005) remained associated with mortality. Conclusions : Although a great improvement has been achieved in the last decades in controlling IM, our study indicates that the mortality rate in this group of patients remains high. Cancer and cardiac involvement are important causes of death, and also prognostic factors for mortality in our group of patients. A careful search for cardiac involvement should be done in every patient with IM.
引用
收藏
页码:205 / 215
页数:11
相关论文
共 28 条
  • [1] Askanas Valerie, 1993, Current Opinion in Rheumatology, V5, P732
  • [2] PROGNOSTIC FACTORS IN POLYMYOSITIS - DERMATOMYOSITIS - A COMPUTER-ASSISTED ANALYSIS OF 92 CASES
    BENBASSAT, J
    GEFEL, D
    LARHOLT, K
    SUKENIK, S
    MORGENSTERN, V
    ZLOTNICK, A
    [J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (03): : 249 - 255
  • [3] POLYMYOSITIS AND DERMATOMYOSITIS .2.
    BOHAN, A
    PETER, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) : 403 - 407
  • [4] POLYMYOSITIS AND DERMATOMYOSITIS .1.
    BOHAN, A
    PETER, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) : 344 - 347
  • [5] COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS
    BOHAN, A
    PETER, JB
    BOWMAN, RL
    PEARSON, CM
    [J]. MEDICINE, 1977, 56 (04) : 255 - 286
  • [6] Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study
    Buchbinder, R
    Forbes, A
    Hall, S
    Dennett, X
    Giles, G
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (12) : 1087 - 1095
  • [7] Relation between dermatomyositis and polymyositis and cancer
    Callen, JP
    [J]. LANCET, 2001, 357 (9250) : 85 - 86
  • [8] Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies?
    Chinoy, H
    Ollier, WER
    Cooper, RG
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (06) : 707 - 713
  • [9] Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features -: A longitudinal study of 162 cases
    Dankó, K
    Ponyi, A
    Constantin, T
    Borgulya, G
    Szegedi, G
    [J]. MEDICINE, 2004, 83 (01) : 35 - 42
  • [10] Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis
    Fathi, M
    Dastmalchi, M
    Rasmussen, E
    Lundberg, IE
    Tornling, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (03) : 297 - 301